Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: a randomized controlled trial.

Alaimo, Giuseppe; Di Marco, Vito; Ferraro, Donatella; Di Stefano, Rosa; Porrovecchio, Salvatore; D'Angelo, Francesca; Calvaruso, Vincenza; Craxì, Antonio; Almasio, Piero Luigi

Alaimo, Giuseppe; Di Marco, Vito; Ferraro, Donatella; Di Stefano, Rosa; Porrovecchio, Salvatore; D'Angelo, Francesca; Calvaruso, Vincenza; Craxì, Antonio; Almasio, Piero Luigi.

Affiliation

Alaimo G; Cattedra di Gastroenterologia, University of Palermo, Piazza delle Cliniche 2, Palermo 90127, Italy.

World J Gastroenterol ; 12(42): 6861-4, 2006 Nov 14.

Article in En | MEDLINE | ID: mdl-17106937

Subject(s)

Antiviral Agents/therapeutic use; Hepacivirus/genetics; Hepatitis C, Chronic/drug therapy; Interferon Type I/therapeutic use; Ribavirin/therapeutic use; Adult; Antiviral Agents/administration & dosage; Antiviral Agents/adverse effects; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis C, Chronic/prevention & control; Humans; Interferon Type I/administration & dosage; Interferon Type I/adverse effects; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Recurrence; Ribavirin/administration & dosage; Ribavirin/adverse effects; Treatment Outcome; Viral Load

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Antiviral Agents / Ribavirin / Interferon Type I / Hepacivirus / Hepatitis C, Chronic Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: World J Gastroenterol Journal subject: GASTROENTEROLOGIA Year: 2006 Type: Article Affiliation country: Italy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google